共 55 条
[1]
Beasley GM(2009)A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US J Am Coll Surg 208 706-715
[2]
Caudle A(2008)Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion Ann Surg Oncol 15 2195-2205
[3]
Petersen RP(2004)Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma Am J Surg 188 532-537
[4]
Beasley GM(2009)Final Version of 2009 AJCC melanoma staging and classification J Clin Oncol. 27 6199-206-247
[5]
Petersen RP(1998)Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion Semin Surg Oncol 14 238-145
[6]
Yoo J(2005)Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale J Support Oncol 3 139-2257
[7]
Ueno T(2008)Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire Cancer 112 2249-220
[8]
Ko SH(1995)Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument Lung Cancer 12 199-1150
[9]
Grubbs E(2009)Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaire Value Health 12 1144-2578
[10]
Pruitt SK(2009)Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis Ann Surg Oncol 16 2570-316